In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Johnson & Johnson (NYSE:JNJ) in relation to its major competitors in the Pharmaceuticals industry. By closely examining key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and highlight company's performance in the industry.
Johnson & Johnson Background
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Johnson & Johnson | 30.86 | 5.62 | 4.82 | 5.78% | $6.82 | $14.6 | 7.3% |
Eli Lilly and Co | 132.70 | 67.89 | 20.37 | 19.91% | $3.03 | $7.57 | 28.1% |
Novo Nordisk A/S | 46.12 | 35.96 | 16.62 | 22.01% | $28.51 | $55.85 | 36.95% |
Merck & Co Inc | 923.29 | 7.94 | 5.61 | 11.87% | $6.95 | $11.7 | 6.71% |
Novartis AG | 25.07 | 4.50 | 4.61 | 19.99% | $4.18 | $8.75 | 7.39% |
AstraZeneca PLC | 33.67 | 5.08 | 4.37 | 2.52% | $2.18 | $9.72 | 7.29% |
Bristol-Myers Squibb Co | 13.30 | 3.53 | 2.37 | 6.03% | $4.45 | $8.73 | 0.62% |
Zoetis Inc | 38.79 | 18.02 | 10.64 | 10.42% | $0.83 | $1.49 | 8.48% |
GSK PLC | 13.93 | 5.08 | 2.26 | 2.64% | $1.78 | $5.63 | -1.17% |
Takeda Pharmaceutical Co Ltd | 39.04 | 1.02 | 1.66 | -0.69% | $202.28 | $699.51 | 4.07% |
Viatris Inc | 8.85 | 0.77 | 1.04 | 1.59% | $1.22 | $1.69 | -3.34% |
Dr Reddy's Laboratories Ltd | 20.31 | 3.96 | 3.91 | 5.29% | $22.42 | $42.2 | 6.57% |
Jazz Pharmaceuticals PLC | 154.66 | 2.32 | 2.36 | 4.19% | $0.33 | $0.87 | 3.35% |
Average | 120.81 | 13.01 | 6.32 | 8.81% | $23.18 | $71.14 | 8.75% |